Skip to main content
Figure 9 | Orphanet Journal of Rare Diseases

Figure 9

From: Compounds that correct F508del-CFTR trafficking can also correct other protein trafficking diseases: an in vitro study using cell lines

Figure 9

F508del-CFTR correctors do not functionally correct V2R mutants. Cyclic AMP accumulation assays are shown for cells expressing V2R V206D (A) or V2R L292P (B) treated with correctors for 24 h. Data shown are means ± S.E.M. (n = 3 independent experiments). None of the compound treatments were statistically significant from the DMSO control with a one-way ANOVA.

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172